Court Opinion

ID: 9353223
Source: CourtListenerOpinion
Date Created: 2023-01-11 15:00:47.292365+00
Date Added: 2024-06-11T17:09:12.806820
License: Public Domain

UNITED STATES DISTRICT COURT
                                  FOR THE DISTRICT OF COLUMBIA

    GLYCOBIOSCIENCES, INC.,

                             Plaintiff,                        Civil Action No. 22-1264 (BAH)

                             v.                                Chief Judge Beryl A. Howell

    VICHY LABORATORIES, S.A. and

    L’ORÉAL, S.A.

                            Defendants.

                               MEMORANDUM OPINION AND ORDER

         Plaintiff Glycobiosciences, Inc., a Canadian cosmetic and pharmaceutical company, owns

two patented formulae that are allegedly being infringed by Vichy Laboratories, S.A. and L’Oréal,

S.A. (collectively, “defendants”). 1             Plaintiff sued defendants, alleging claims of patent

infringement. See 35 U.S.C. §101 et. seq. Defendants now move to dismiss, claiming, inter alia,

that personal jurisdiction is lacking over them in this judicial district. For the reasons below,

defendants’ motion to dismiss is granted, without prejudice.

    I.   BACKGROUND

         The relevant factual and procedural background is summarized below.

         A. Factual Background

1
         Vichy Laboratories S.A. is named as a defendant in this action, but defendants clarify that no entity with that
name exists and that an entity named “Vichy LLC” is wholly owned by L’Oréal USA with “Vichy” used as a brand
name. Defs.’Mot. at 5 (explaining that “Vichy” is “a brand used by L’Oréal USA and there is a separate LLC—named
Vichy LLC—for that brand. L’Oréal USA is the only member of Vichy LLC and the LLC has no employees or
operations.”). Plaintiff concedes that Vichy Laboratories S.A. does not exist, and Vichy LLC is merely part of L’Oréal
USA. See Pl’s Opp’n at 1 n.1 (“Defendant Vichy Laboratories is apparently a non-entity that is simply a brand name
of Defendant L’Oréal S.A. . . . Thus[,] the Defendants collapse back into L’Oréal S.A.”). Consequently, assessment
of personal jurisdiction focuses only on L’Oréal S.A.

                                                           1
        Plaintiff is a successful Canadian cosmetic and pharmaceutical company that owns the

following two patents at issue: (1) Patent No. 9,821,005, issued by the U.S. Patent and Trademark

Office (“USPTO”) to plaintiff on November 21, 2017, for the formula of a gel containing specific

percentages of bio-fermented sodium hyaluronate, hydroxyethylcellulose, polyethylene glycol,

methylparaben, and water, Pls.’ Compl. (“Compl.”), ¶¶ 1, 12, 17, ECF No. 1; and (2) Patent No.

10,322,142, issued by USPTO to plaintiff on June 18, 2019, for the formula of a polymer matrix

composed of specific percentages of bio-fermented sodium hyaluronate, non-ionic polymer,

polyethylene glycol, and water, along with the inclusion “of an active therapeutic ingredient in

addition to the Hyaluronic Acid,” id. ¶¶ 1, 13, 18. Both patents expire on August 5, 2035. Id.

¶ 13.

        L’Oréal S.A., a corporation with its principal place of business and headquarters in Clichy,

France, allegedly sells and distributes products using formulas similar to those that plaintiff has

patented. See Id. ¶ 3, 19. Specifically, L’Oréal S.A. manufactures, distributes, and sells three

cosmetics under the name Revitalift, which “contain high concentrations of Hyaluronic Acid in a

Polymer matrix which includes a non-ionic polymer and are formulations that have all of the

elements of one or more of the claims of the Glyco Patents and/or have formulae that are equivalent

to the claimed formulas.” Id. ¶ 14. Likewise, “Vichy manufactures and sells” three products under

the name “Liftactiv,” each “contain[ing] high concentrations of Hyaluronic Acid in a Polymer

matrix which includes a non-ionic polymer and are formulations that have all of the elements of

one or more of the claims of the Glyco Patents and/or have formulae that are equivalent to the

claimed formulas.” Id. ¶ 15.

        L’Oréal S.A. sells and distributes these products in the United States, including in the

District of Columbia, exclusively through L’Oréal d/b/a L’Oréal USA (“L’Oréal USA”). See id.

                                                 2
¶¶ 3–4, 6. Apart from the contacts of L’Oréal USA, the only other contact that L’Oréal S.A. has

in the United States is allegedly that an “Assistant Vice President – DIPI International Head of

Instrumental Cosmetics & Digital,” named Dr. Roy P. Diaz, works out of an office located at 111

Terminal Avenue in Clark, New Jersey. Pl.’s Opp’n, Ex. C at 1 (Email, dated on March 22, 2022,

to plaintiff’s representative from Dr. Diaz with the latter’s job title and office address in the

signature block of the email) (“Diaz Email”), ECF No. 22-1.

       B. Procedural Background

       In an effort to resolve the dispute amicably, plaintiff contacted and presented the two patent

licenses at issue to L’Oréal S.A., with a request that defendant stop selling the allegedly patent-

infringing products. See Compl. ¶¶ 16, 24, 30, 36, 40. L’Oréal S.A. declined the request, see id.,

prompting plaintiff to initiate the instant lawsuit, claiming that defendants willfully infringed both

patents. Id. at 10, ¶¶ A-G. Plaintiff seeks a permanent injunction, compensatory damages,

enhanced damages, attorneys’ fees, prejudgment interest, and post judgment interest. Id. at 10, ¶¶

H-M.

       Defendants timely moved to dismiss for lack of personal jurisdiction, improper service,

and improper venue, see Defs.’ Mot. to Dismiss (“Defs.’ Mot”), ECF No. 10, which motion

plaintiff opposes, see Pl.’s Opp’n to. Mot. to Dismiss (“Pl.’s Opp’n”), ECF No. 12. With briefing

completed, see Defs.’ Reply Mem. in Supp. Mot. to Dismiss (“Defs.’ Reply”), ECF No. 13,

defendants’ motion is now ripe for resolution.

II.    LEGAL STANDARD

       “Personal jurisdiction is ‘an essential element of the jurisdiction of a district . . . court,’

without which the court is ‘powerless to proceed to an adjudication.’” Jankovic v. Int’l Crisis

Grp., 494 F.3d 1080, 1086 (D.C. Cir. 2007) (alteration in original) (quoting Ruhrgas AG v.

Marathon Oil Co., 526 U.S. 574, 584 (1999)). To survive a motion to dismiss for lack of personal
                                                  3
jurisdiction, under Federal Rule of Civil Procedure 12(b)(2), the plaintiff must “make a prima facie

showing of the pertinent jurisdictional facts.” Livnat v. Palestinian Auth., 851 F.3d 45, 56–57

(D.C. Cir. 2017) (quoting First Chi. Int’l v. United Exch. Co., 836 F.2d 1375, 1378 (D.C. Cir.

1988)). The prima facie showing requires specific factual allegations connecting each defendant

to the forum. First Chi. Int'l, 836 F.2d at 1378. While the complaint’s factual allegations must be

accepted as true, and all reasonable inferences must be drawn in plaintiff’s favor, Bernhardt v.

Islamic Republic of Iran, 47 F.4th 856, 861 (D.C. Cir. 2022), mere conclusory statements and bare

allegations are insufficient, Livnat, 851 F.3d at 57.

       Unlike on a motion to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6), the

court “may consider materials outside the pleadings in deciding whether to grant a motion to

dismiss for lack of jurisdiction.” Jerome Stevens Pharms., Inc. v. FDA, 402 F.3d 1249, 1253 (D.C.

Cir. 2005) (citing Herbert v. Nat’l Acad. of Scis., 974 F.2d 192, 197 (D.C. Cir. 1992)). Indeed,

jurisdictional arguments may be premised on the “pleadings, bolstered by such affidavits and other

written materials as [the parties] can otherwise obtain.” Mwani v. bin Laden, 417 F.3d 1, 7 (D.C.

Cir. 2005). “When deciding personal jurisdiction without an evidentiary hearing—as here—the

‘court must resolve factual disputes in favor of the plaintiff.’” Livnat, 851 F.3d at 57 (quoting

Helmer v. Doletskaya, 393 F.3d 201, 209 (D.C. Cir. 2004)). The Court, however, “‘need not accept

inferences drawn by plaintiffs if such inferences are unsupported by the facts.’” Id. (quoting

Helmer, 393 F.3d at 209).

III.   DISCUSSION

       Defendants argue that the Court lacks the power to adjudicate this dispute because L’Oréal

S.A. is a foreign company whose contacts in the United States are solely through L’Oréal USA,

which operates as a separate legal entity and is not a party to the lawsuit. According to defendants,

                                                  4
L’Oréal S.A. lacks the requisite minimum contacts in the United States to satisfy the requirements

for personal jurisdiction under the Fifth Amendment’s Due Process Clause. Mot. at 6; Reply at 5;

see also U.S. CONST. amend. V. 2 Defendants are right.

         It is hornbook law that “a defendant outside a forum’s borders may be subject to suit” only

if the defendant has “‘certain minimum contacts with [the forum] such that the maintenance of the

suit does not offend traditional notions of fair play and substantial justice.” Livnat v, 851 F.3d at

48 (quotation marks omitted) (quoting Int’l Shoe Co. v. Wa., 326 U.S. 310, 316 (1945)). The D.C.

Circuit has further “explained that the Fifth Amendment’s Due Process Clause protects defendants

from being subject to the binding judgments of a forum with which they have established no

meaningful contacts, ties, or relations, and requires fair warning that a particular activity may

subject them to the jurisdiction of a foreign sovereign.” Id. (cleaned up).

         “The traditional personal jurisdiction analysis asks first whether an applicable long-arm

statute authorizes the court to hear the case, and second whether doing so comports with due

process.” Atchley v. AstraZeneca UK LTD, 22 F.4th 204, 231 (D.C. Cir. 2022). Plaintiff’s claim

of specific jurisdiction is premised on Federal Rule of Civil Procedure 4(k)(2), which provides as

to claims arising under federal law that “serving a summons or filing a waiver of service establishes

personal jurisdiction over a defendant if: (A) the defendant is not subject to jurisdiction in any

state’s courts of general jurisdiction; and (B) exercising jurisdiction is consistent with the United

States Constitution and laws.” FED. R. CIV. P. 4(k)(2). In this way, Rule 4(k)(2) operates

“essentially [as] a federal long arm-statute.” Atchley, 22 F.4th at 232 (cleaned up). When Rule

4(k)(2) is invoked as the basis for the exercise of personal jurisdiction over a defendant not subject

2
         Defendants also argue that venue is improper and plaintiff’s attempts at service is insufficient, Defs.’Mot. at
6–9, but these alternative arguments need not be reached because this motion is resolved on personal jurisdiction
grounds.

                                                           5
to jurisdiction in any state’s courts of general jurisdiction, the relevant question is “whether a

defendant has sufficient contacts with the United States as a whole to justify the exercise of

personal jurisdiction under the Due Process Clause of the Fifth Amendment.” Mwani, 417 F.3d at

11; see also Atchley, 22 F.4th at 232 (quotation marks omitted) (“Besides proper service of process,

[Rule 4(k)(2)] requires only that jurisdiction be consistent with the United States Constitution and

laws.”). “Apart from the scope of the forum and potential federalism considerations, the Fifth and

Fourteenth Amendment Due Process inquiries are generally analogous.” Atchley, 22 F.4th at 232;

see also Livnat, 851 F.3d at 54 (explaining that “the Supreme Court and this court have applied

Fourteenth Amendment’s personal-jurisdictional standards in Fifth Amendment cases”); but see

Bristol-Myers Squibb Co. v. Super. Ct. of Cal., 137 S. Ct. 1773, 1783–84 (2017) (“[W]e leave open

the question whether the Fifth Amendment imposes the same restrictions [as the Due Process

Clause of the Fourteenth Amendment] on the exercise of personal jurisdiction by a federal court.”).

       “The Supreme Court has developed two distinct analyses of the circumstances in which a

forum state may, consistent with due process, authorize its courts to exercise contact-based

personal jurisdiction over a defendant[:]” general jurisdiction and specific jurisdiction. Erwin-

Simpson v. AirAsia Berhad, 985 F.3d 883, 888 (D.C. Cir. 2021). General jurisdiction, which

“‘permits a court to assert jurisdiction over a defendant based on a forum connection unrelated to

the underlying suit[,]’” Livnat, 851 F.3d at 56 (quoting Walden, 571 U.S. at 283 n.6), is only

established when a plaintiff has shown that the defendant’s “affiliations with the State are so

continuous and systematic as to render them essentially at home in the forum State[,]” Goodyear

Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915, 919 (2011) (quotation marks omitted).

Plaintiff does not argue that general jurisdiction may be exercised over L’Oréal S.A., see Pl.’s

                                                 6
Opp’n at 4–6, leaving the sole issue of whether the requirements for specific jurisdiction are

satisfied.

         Unlike general jurisdiction, specific jurisdiction is based on “acts of a defendant that touch

and concern the forum.” Steinberg v. Int’l Criminal Police Org., 672 F.2d 927, 928 (D.C. Cir.

1981); see also Ford Motor Co. v. Montana Eighth Judicial District, 141 S.Ct. 1017, 1031 (2021)

(alteration in original) (explaining that specific jurisdiction “covers defendants less intimately

connected with a [forum], but only as to a narrower class of claims”). The “‘essential foundation

of specific jurisdiction’ is the ‘relationship among the defendant, the forum, and the litigation.’”

Atchley, 22 F.4th at 234 (quotation marks omitted) (quoting Ford, 141 S. Ct. at 1028). To show

that the court’s exercise of specific jurisdiction over the defendant satisfies due process, plaintiff

must establish the following: “(1) minimum contacts demonstrating that the defendant[s]

purposefully availed [themselves] of the forum; (2) relatedness between the contacts and the claim;

and (3) compliance with ‘fair play and substantial justice.’” Id. “These rules derive from and

reflect two sets of values—treating defendants fairly and protecting interstate federalism.” Ford

Motor Co., 141 S. Ct. at 1025 (quotation marks omitted). Additionally, “[p]leading specific

personal jurisdiction under Rule 4(k)(2) requires demonstrating a close nexus between the United

States, the foreign defendant’s conduct, and the plaintiff’s claim.” Bernhardt, 47 F.4th at 864.

        As a threshold matter, the parties dispute whether L’Oréal USA’s contacts in the United

States may be imputed to L’Oréal S.A. “Ordinarily, a defendant corporation’s contacts with a

forum may not be attributed to affiliated corporations.” Johnson-Tanner v. First Cash Fin. Servs.,

Inc., 239 F. Supp. 2d 34, 38 (D.D.C. 2003). To tie a parent corporation’s contacts to its subsidiary,

the plaintiff must demonstrate that the corporate veil between the parent and the subsidiary’s veil

should be pierced, at least for jurisdictional purposes. Goodyear, 564 U.S. at 930; see also I.A.M.

                                                   7
Nat. Pension Fund, Ben. Plan A v. Wakefield Indus., Div. of Capehart Corp., 699 F.2d 1254, 1259

(D.C. Cir. 1983) (explaining that “where the two corporations are not really separate entities[,]

service on the parent will reach a foreign subsidiary”). “Whether one corporation is the alter ego

of another is a question of law to be decided by the court.” Johnson-Tanner, 239 F. Supp. 2d at

38. In other words, a plaintiff must show by affirmative evidence the following: “(1) is there such

unity of interest and ownership that the separate personalities of the corporation and the individual

no longer exist?; and (2) if the acts are treated as those of the corporation alone, will an inequitable

result follow?” Labadie Coal Co. v. Black, 672 F.2d 92, 97 (D.C. Cir. 1982).

       Plaintiff makes only a feeble effort to show that either requirement for alter ego liability is

satisfied. In plaintiff’s view, the single allegation that “L’Oréal SA is the developer, formulator[,]

and primary manufacturer of the accused products and that L’Oréal USA receives at least

components and the final formulated product from L’Oréal S.A.” suffices to support the exercise

of “jurisdiction and venue in a patent infringement” action. Pl.’s Opp’n at 5–6. This conclusory

allegation is insufficient to demonstrate that L’Oréal S.A. “so dominated [L’Oréal USA] . . . as to

negate its separate personality.” Hart v. Dep't of Agric., 112 F.3d 1228, 1231 (D.C. Cir. 1997)

(quotation marks omitted). Plaintiff has not otherwise explained how the two-pronged inquiry in

Labadie Coal Company for piercing the corporate veil between L’Oréal S.A. and L’Oréal USA,

and attributing the latter’s contacts to the former, is met, particularly when set against the thorough

declaration submitted by defendants describing the independence of the two companies. See, e.g.,

BPA Int’l, Inc. v. Kingdom of Sweden, 281 F. Supp. 2d 73, 83 (D.D.C. 2003) (“[Plaintiff] produces

no evidence to counter the sworn affidavits submitted by Telia that there are no shared officers or

directors between Telia and TICI, financial records and account books are maintained separately,

and Telia has no role in TICI's day-to-day operations or corporate governance. . . . The mere

                                                   8
corporate relationship between Telia and TICI, without more, does not suffice.”); United States

ex. rel. Scollick v. Narula, 215 F. Supp. 3d 26, 37 (D.D.C. 2016) (citation omitted) (“With regard

to all the alleged alter ego relationships, plaintiff relator states that the defendants ‘have such a

unity of interest and ownership that the individuality of each entity ceased and they functioned as

a single entity.’ This is a legal conclusion insufficient to state a claim for relief.”).

        Defendants explain, in a declaration from L’Oréal USA’s Senior Vice President of Finance,

Roy Rabinowitz, that L’Oréal USA “makes stringent efforts to observe standard corporate

formalities.” Defs.’ Mot., Ex. 1, Declaration of Roy Rabinowitz (“Rabinowitz Decl.”) ¶ 5, ECF

No. 10-1; see also id. at 5. This declaration further states that, “while L’Oréal USA keeps L’Oréal

S.A. informed about major issues and receives overall strategic guidance from L’Oréal S.A., it

operates independently from its parent,” Rabinowitz Decl. ¶ 5, providing as specific examples of

such independence between the companies that “L’Oréal USA maintains separate licensing and

distribution contracts, manufactures and distributes its own products, has its own board of

directors, issues separate financial statements, files separate tax returns, and maintains a workforce

separate from L’Oréal S.A.,” as well as “its own departments in areas such as finance, human

resources, legal, corporate communications, customer relations, Research and Innovation, and

marketing and advertising.” Id. Plaintiff makes no effort to rebut the Rabinowitz Declaration’s

observation that the corporate formalities between L’Oréal S.A. and L’Oréal USA are rigorously

observed, which confirms that the corporate veil between the two corporate entities has not and

may not be breached such that L’Oréal USA’s contacts can be attributed to L’Oréal S.A.

        Stripped of the domestic subsidiary’s contacts, L’Oréal S.A.’s sole contact in the United

States is, allegedly, that Mr. Diaz, L’Oréal S.A.’s “Assistant Vice President - DIPI International

Head of Instrumental Cosmetics & Digital,” works out of an office based in New Jersey, and

                                                    9
plaintiff’s additional allegation that “Mr. Diaz [presumably] has a staff and that other employees

are also located in the New Jersey facility.” Pl.’s Opp’n at 6. Nothing in the Diaz Email cited by

plaintiff shows, however, that Mr. Diaz works for L’Oréal S.A.; instead, his signature block merely

mentions that he works for “L’ORÉAL Research & Innovation” at 111 Terminal Avenue in Clark,

New Jersey, which, as the Rabinowitz Declaration clarifies, is a facility “owned and operated by

L’Oréal USA,” Rabinowitz Decl. ¶ 7. Furthermore, Dr. Roy Diaz attests in his declaration that he

is an employee of L’Oréal USA, not L’Oréal S.A. Defs.’ Reply, Ex. 1, Declaration of Dr. Roy

Diaz ¶ 3 (“I have never been employed by L’Oréal S.A. and have never been an officer of that

company. Since September of 2014, I have been employed by L’Oréal USA[.]”), ECF No. 13-1.

       Even assuming that L’Oréal S.A. does have an office in New Jersey, and that Mr. Diaz

works for L’Oréal S.A., rather than L’Oréal USA (which plaintiff has not shown), plaintiff does

not explain how that this singular office in one state is enough to evince that L’Oréal S.A. has

“avail[ed] itself of the privilege of conducting activities within the forum[.]” Ford, 141 S. Ct. at

1024 (quotation marks omitted). For example, plaintiff has not shown how large this office is,

how many employees work at this office, or what this office even does for L’Oréal S.A.’s business.

Plaintiff’s conclusory inference that Mr. Diaz presumably has a staff and employees need not be

accepted either. See Helmer, 393 F.3d at 209 (explaining that the court “need not accept inferences

drawn by plaintiffs if such inferences are unsupported by the facts” when deciding personal

jurisdiction without an evidentiary hearing). L’Oréal S.A. does not have sufficient minimum

contacts in the United States to satisfy the requirements for due process.

       In addition to flunking the minimum contacts requirement, plaintiff has not explained how

L’Oréal S.A.’s presumed single employee in a single office is connected to its claim of patent

infringement, or how exercising specific jurisdiction on either defendant would comport with

                                                10
“traditional notions of fair play and substantial justice.” Plaintiff’s only relevant argument to the

relatedness inquiry is that “[o]ther relevant employees frequent the United States for business

purposes related to the subject matter of this suit.” Pl.’s Opp’n at 6. Even if true, plaintiff’s

argument is far too general since the mere fact that some L’Oréal S.A. employees, who work on

the general “subject matter” of patents, “frequent” the United States falls well short of satisfying

the relatedness inquiry. See Berhnardt, 47 F.4th at 864 (“Pleading specific personal jurisdiction

under Rule 4(k)(2) requires demonstrating a close nexus between the United States, the foreign

defendant's conduct, and the plaintiff's claim.”); see also Livnet, 851 F.3d at (holding that, in a

lawsuit seeking to hold the Palestinian Authority vicariously liable for an armed attack at a holy

site in the West Bank, the plaintiff’s “declaration from a professor asserting that the Palestinian

Authority encourages terrorism against Jews and Israelis in order to influence U.S. policy in the

Palestinian Authority’s favor . . . establishe[d] no link between that practice and the . . . attack”).

Plaintiff’s abbreviated briefing on this point, see Pl.’s Opp’n at 4–6, can only be explained by its

flawed legal assumption that L’Oréal USA’s contacts may be automatically imputed to L’Oréal

S.A, see id. at 6 (“L’Oréal S.A. sells accused products into and in the United States, directly and

through its wholly owned subsidiary, that is sufficient for and venue in a patent infringement

suit.”), an assumption that is inconsistent with governing law on imputing a subsidiary’s contacts

to its parent.

    IV.      CONCLUSION AND ORDER

          For the foregoing reasons, L’Oréal USA’s contacts cannot be imputed to L’Oréal S.A., and

plaintiff has failed to demonstrate that exercising personal jurisdiction over L’Oréal S.A. would

satisfy the requirements of the Fifth Amendment’s Due Process Clause. Accordingly, it is hereby

          ORDERED that defendant’s Motion to Dismiss, ECF No. 19, is GRANTED; it is further

                                                  11
       ORDERED that the plaintiff’s complaint is dismissed, without prejudice, for lack of

       personal jurisdiction over defendants; and it is further

       ORDERED that the Clerk of the Court is directed to close this case.

       SO ORDERED.

Date: January 11, 2023

                                                     __________________________

                                                     BERYL A. HOWELL

                                                     Chief Judge

                                                12